Yu-Waye Chu, Senior VP Clinical Development at FATE THERAPEUTICS INC (FATE), sold 3,275 shares at $82.91 ($273K) on 2021-04-16, disclosed to the SEC on 2021-04-20.
Open-market sale of $273k FATE by Senior VP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.80 | 875 | $72K | 26.2% |
| 2 | $82.91 | 900 | $75K | 27.4% |
| 3 | $84.41 | 1,500 | $127K | 46.4% |
| Total | $83.30 avg | 3,275 | $273K | 100% |
| Filing → |
| FATE | SELL | 2023-04-19 | $17K | — | Filing → |
| FATE | SELL | 2023-01-11 | $41K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |